- Home
- PGEN vs PSBD Comparison
PGEN vs PSBD Comparison
Compare PGEN & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PGEN
- PSBD
- Stock Information
- Founded
- PGEN 1998
- PSBD 2009
- Country
- PGEN United States
- PSBD United States
- Employees
- PGEN N/A
- PSBD N/A
- Industry
- PGEN Biotechnology: Pharmaceutical Preparations
- PSBD
- Sector
- PGEN Health Care
- PSBD
- Exchange
- PGEN Nasdaq
- PSBD Nasdaq
- Market Cap
- PGEN 404.4M
- PSBD 452.6M
- IPO Year
- PGEN N/A
- PSBD 2024
- Fundamental
- Price
- PGEN $1.45
- PSBD $14.48
- Analyst Decision
- PGEN Strong Buy
- PSBD Buy
- Analyst Count
- PGEN 3
- PSBD 4
- Target Price
- PGEN $6.00
- PSBD $14.13
- AVG Volume (30 Days)
- PGEN 1.6M
- PSBD 42.8K
- Earning Date
- PGEN 08-13-2025
- PSBD 08-07-2025
- Dividend Yield
- PGEN N/A
- PSBD 11.72%
- EPS Growth
- PGEN N/A
- PSBD N/A
- EPS
- PGEN N/A
- PSBD N/A
- Revenue
- PGEN $4,201,000.00
- PSBD N/A
- Revenue This Year
- PGEN $158.57
- PSBD N/A
- Revenue Next Year
- PGEN $1,086.91
- PSBD N/A
- P/E Ratio
- PGEN N/A
- PSBD N/A
- Revenue Growth
- PGEN N/A
- PSBD N/A
- 52 Week Low
- PGEN $0.65
- PSBD $11.51
- 52 Week High
- PGEN $2.17
- PSBD $16.85
- Technical
- Relative Strength Index (RSI)
- PGEN 53.70
- PSBD 69.09
- Support Level
- PGEN $1.47
- PSBD $13.80
- Resistance Level
- PGEN $1.59
- PSBD $14.68
- Average True Range (ATR)
- PGEN 0.11
- PSBD 0.27
- MACD
- PGEN 0.01
- PSBD 0.04
- Stochastic Oscillator
- PGEN 63.64
- PSBD 80.44
About PGEN Precigen Inc.
Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.
About PSBD Palmer Square Capital BDC Inc.
Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.